PALI
Palisade BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PALI Profile
Palisade Bio, Inc.
A clinical-stage biopharmaceutical company focused on developing oral therapies for serious diseases associated with disruption of the mucosal barrier that protects the gastrointestinal tract
1902 Wright Place, Suite 200, Carlsbad, California1
--
Palisade Bio, Inc., founded in 1997, is a biopharmaceutical company dedicated to providing treatment options for central nervous system diseases using its unique human neural stem cell technology. The company will commercialize this technology to make it a tool for discovering next-generation small molecule drugs and create a biological cell therapy to treat central nervous system diseases. The company currently has laboratories and offices in Rockville, Maryland, as well as experimental equipment in San Diego and China. Neuralstem, Inc., develops and maintains a series of patents and patent applications that form the proprietary basis of its research and development efforts. The Company owns or exclusively licenses thirty (30) US and foreign granted patents and forty-two (42) US and foreign patent applications in the field of regenerative medicine, covering its stem cell technology and its small molecule compounds.
